Lobbying

Senseonics SENS's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.

SenseonicsSENS

Senseonics stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Senseonics lobbying by quarter
Senseonics lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$01
Q2 2024$00
Q3 2024$60K1
Q4 2024$60K1
Q1 2025$60K1
Q2 2025$10K1
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Medicare and Medicaid$290K · 10 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)5 reports
  • Health & Human Services, Dept of (HHS)5 reports
  • HOUSE OF REPRESENTATIVES5 reports

Firms it paid

Firm
Manatt, Phelps, and Phillips$190K8 quarters
Akin Gump Strauss Hauer & Feld$100K6 quarters

Former officials lobbying for it

Former position
NICHOLAS WILLIAM BATH jrHealth Policy Director of the U.S. Senate Committee on Health, Education, Labor and PensionsQ4 2024

Lobbying reports

Filed by
07/20for Q2Manatt, Phelps, and PhillipsUnder $5,000
04/20for Q1Manatt, Phelps, and PhillipsUnder $5,000
01/13for Q4 2025Manatt, Phelps, and PhillipsUnder $5,000
25/10/16for Q3 2025Manatt, Phelps, and PhillipsUnder $5,000
25/07/21for Q2 2025Manatt, Phelps, and Phillips$10K
25/04/21for Q1 2025Manatt, Phelps, and Phillips$60K
25/01/15for Q4 2024Manatt, Phelps, and Phillips$60K
24/10/23for Q3 2024Manatt, Phelps, and Phillips$60K
24/10/21for Q3 2024Manatt, Phelps, and Phillips$60K
24/10/17for Q3 2024Manatt, Phelps, and PhillipsUnder $5,000
24/10/14for Q3 2024Manatt, Phelps, and PhillipsUnder $5,000
24/04/19for Q1 2024Akin Gump Strauss Hauer & FeldUnder $5,000
24/01/19for Q4 2023Akin Gump Strauss Hauer & Feld$20K
23/10/20for Q3 2023Akin Gump Strauss Hauer & Feld$20K
23/07/20for Q2 2023Akin Gump Strauss Hauer & Feld$20K
23/04/20for Q1 2023Akin Gump Strauss Hauer & Feld$20K
23/01/20for Q4 2022Akin Gump Strauss Hauer & Feld$20K